Los Angeles Biotech Trending News

Anivive Licenses Novel Canine Cancer Therapeutic to Expand Sales and Accelerate Pipeline

LONG BEACH, Calif.: LONG BEACH, Calif., Jan. 12, 2022 /PRNewswire/ — Anivive Lifesciences, a pet health technology company dedicated to solving unmet needs in the veterinary community, announces that Dechra Pharmaceuticals PLC (Dechra) has acquired […]

No Picture
Los Angeles Biotech Trending News

Glaukos’ iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its iDose® TR sustained-release […]

No Picture
Los Angeles Biotech Trending News

AccessHope and Emory Healthcare Announce Collaboration, Extending Access to Cancer Expertise in the Southeastern United States and Beyond

DUARTE, Calif., & ATLANTA–(BUSINESS WIRE)–AccessHope and Emory Healthcare announce collaboration which will extend access to cancer expertise in the southeastern United States and beyond. Click to view original post

No Picture
Los Angeles Biotech Trending News

Leonard Green & Partners Acquires Majority Stake in Leading Analytical & Life Sciences Testing and Services Provider Pace® from Aurora Capital Partners

LOS ANGELES: LOS ANGELES, Jan. 11, 2022 /PRNewswire/ — Leonard Green & Partners, L.P. ("LGP") today announced that it has acquired a majority stake in Pace® ("Pace" or the "Company"), North America’s leading provider of […]

No Picture
Los Angeles Biotech Trending News

ACELYRIN Appoints Melanie Gloria as Chief Operating Officer

LOS ANGELES: LOS ANGELES, Jan. 11, 2022 /PRNewswire/ — ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates, today […]

No Picture
Los Angeles Biotech Trending News

Neogene Therapeutics Announces Exclusive License with the National Cancer Institute for a Portfolio of T Cell Receptors (TCR) Targeting KRAS and TP53 Mutations for the Treatment of Cancer

SANTA MONICA, Calif. & AMSTERDAM–(BUSINESS WIRE)–Neogene Therapeutics, Inc., a biotechnology company pioneering a new class of fully individualized T cell receptor (TCR) therapies to treat cancer, today announced an exclusive, worldwide license agreement with the […]

No Picture
Los Angeles Biotech Trending News

AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE THAT KARMA BIOTECHNOLOGIES WILL RECEIVE THE SECOND AMGEN GOLDEN TICKET

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Jan. 10, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) and BioLabs LA at the Lundquist Institute today announced that Karma Biotechnologies has been awarded the second Amgen Golden Ticket in Southern […]